Your browser doesn't support javascript.
loading
Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials
Palmerini, Tullio; Benedetto, Umberto; Bacchi-Reggiani , Letizia; Della Riva, Diego; Biondi-Zoccai, Giuseppe; Feres, Fausto; Abizaid, Alexandre; Hong, Myeong-Ki; Kim, Byeong-Keuk; Jang, Yangsoo; Kim, Hyo-Soo; Park, Kyung Woo; Genereux, Philippe; Bhatt, Deepak L; Orlandi, Carlotta; De Servi, Stefano; Petrou, Mario; Rapezzi, Claudio; Stone, Gregg W.
Afiliação
  • Palmerini, Tullio; Dipartimento Cardio-Toraco-Vascolare, University of Bologna. Bologna. IT
  • Benedetto, Umberto; Oxford Heart Center, Oxford University. Oxford. GB
  • Bacchi-Reggiani , Letizia; Dipartimento Cardio-Toraco-Vascolare, University of Bologna. Bologna. IT
  • Della Riva, Diego; Dipartimento Cardio-Toraco-Vascolare, University of Bologna. Bologna. IT
  • Biondi-Zoccai, Giuseppe; Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome. Latina. IT
  • Feres, Fausto; Istituto Dante Pazzanese de Cardiologia. São Paulo. BR
  • Abizaid, Alexandre; Istituto Dante Pazzanese de Cardiologia. São Paulo. BR
  • Hong, Myeong-Ki; Severance Cardiovascular Hospital and Science Institute, Yonsei University College of Medicine. Seoul. KR
  • Kim, Byeong-Keuk; Severance Cardiovascular Hospital and Science Institute, Yonsei University College of Medicine. Seoul. KR
  • Jang, Yangsoo; Severance Cardiovascular Hospital and Science Institute, Yonsei University College of Medicine. Seoul. KR
  • Kim, Hyo-Soo; Department of Internal Medicine, Seoul National University Hospital. Seoul. KR
  • Park, Kyung Woo; Department of Internal Medicine, Seoul National University Hospital. Seoul. KR
  • Genereux, Philippe; Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation. New York. US
  • Bhatt, Deepak L; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School. Boston. US
  • Orlandi, Carlotta; Dipartimento Cardio-Toraco-Vascolare, University of Bologna. Bologna. IT
  • De Servi, Stefano; Policlinico S Matteo. Pavia. IT
  • Petrou, Mario; Oxford Heart Center, Oxford University. Oxford. GB
  • Rapezzi, Claudio; Dipartimento Cardio-Toraco-Vascolare, University of Bologna. Bologna. IT
  • Stone, Gregg W; Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation. New York. US
Lancet ; 385(9985): 2371-2782, 2015.
Article em En | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1064575
Biblioteca responsável: BR79.1
Localização: BR79.1
ABSTRACT

BACKGROUND:

Despite recent studies, the optimum duration of dual antiplatelet therapy (DAPT) after coronary drug-eluting stent placement remains uncertain. We performed a meta-analysis with several analytical approaches to investigate mortality and other clinical outcomes with different DAPT strategies.

METHODS:

We searched Medline, Embase, Cochrane databases, and proceedings of international meetings on Nov 20, 2014, for randomised controlled trials comparing different DAPT durations after drug-eluting stent implantation. We extracted study design, inclusion and exclusion criteria, sample characteristics, and clinical outcomes. DAPT duration was categorised in each study as shorter versus longer, and as 6 months or shorter versus 1 year versus longer than 1 year. Analyses were done by both frequentist and Bayesian approaches.

FINDINGS:

We identified ten trials published between Dec 16, 2011, and Nov 16, 2014, including 31,666 randomly assigned patients. By frequentist pairwise meta-analysis, shorter DAPT was associated with significantly lower all-cause mortality compared with longer DAPT (HR 0·82, 95% CI 0·69-0·98; p=0·02; number needed to treat [NNT]=325), with no significant heterogeneity apparent across trials. The reduced mortality with shorter compared with longer DAPT was attributable to lower non-cardiac mortality (0·67, 0·51-0·89; p=0·006; NNT=347), with similar cardiac mortality (0·93, 0·73-1·17; p=0.52). Shorter DAPT was also associated with a lower risk of major bleeding, but a higher risk of myocardial infarction and stent thrombosis. We noted similar results in a Bayesian framework with non-informative priors. By network meta-analysis, patients treated with 6-month or shorter DAPT and 1-year DAPT had higher risk of myocardial infarction and stent thrombosis but lower risk of mortality compared with patients treated with DAPT for longer than 1 year...
Assuntos
Buscar no Google
Coleção SES: Producao_cientifica Base de dados: SES-SP / SESSP-IDPCPROD Assunto principal: Mortalidade / Stents Farmacológicos Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Buscar no Google
Coleção SES: Producao_cientifica Base de dados: SES-SP / SESSP-IDPCPROD Assunto principal: Mortalidade / Stents Farmacológicos Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2015 Tipo de documento: Article